19
total announcements
543321.BO · 15 min delayed
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd has published a newspaper advertisement for its 30th Annual General Meeting scheduled on September 25, 2026, through Video Conferencing or Other Audio Visual Means.
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd has announced the record date, book closure, and cut-off date for its 30th Annual General Meeting (AGM). The record date is September 11, 2026, and the book closure will be from September 12 to 25, 2026. The company will pay the final dividend for the financial year 2025-26 on or after October 1, 2026.
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd has submitted its Business Responsibility and Sustainability Report (BRSR) for FY 2025-26, as per SEBI Listing Regulations.
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd has submitted its Annual Report for the Financial Year 2025-26, along with the Notice of the 30th Annual General Meeting, as per Regulation 34(1) of the SEBI Listing Regulations.
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd has announced the 30th AGM to be held on 25 September 2026, where the re-appointment of Mr. Chintan Nitinkumar Shah as Managing Director for a period of three years will be considered.
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd has announced the resignation of Mr. Ajay Rawat, Assistant Vice President – Research and Development, effective from the close of business hours on 13 November 2026.
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd has published a newspaper advertisement announcing its 30th Annual General Meeting (AGM) to be held on September 25, 2026, through video conferencing.
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd declares final dividend for FY 2025-26, with tax deduction at source (TDS) applicable to shareholders. Resident individuals with aggregate dividend below Rs. 10,000 are exempt from TDS. Shareholders can submit self-declaration forms for lower tax rates or exemptions.
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd has announced a schedule of analyst/investor meetings, which will be held on August 12, 2026, with Ambit Global Private and TA Associate. The meetings will be virtual and will not include any confidential or unpublished price-sensitive information.
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd has announced a schedule of analyst/investor meetings under SEBI regulations, with two virtual meetings on August 12, 2026, with Ambit Global Private and TA Associate.
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd has announced an analyst/investor meeting under SEBI regulations, with a virtual meeting scheduled on August 6, 2026. The company will discuss publicly available information and not share any confidential or unpublished price-sensitive information.
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd has announced an analyst/investor meeting under SEBI regulations, with ChrysCapital Associates participating on August 6, 2026. The meeting will be held virtually and will refer to publicly available information. No unpublished price-sensitive information will be shared.
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd has announced a schedule of analyst/investor meeting under SEBI regulations, with a one-to-one meeting with Motilal Oswal AMC on July 31, 2026.
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd has announced a schedule of Analyst/Institutional Investor Meeting under SEBI regulations, to be held on 30 July 2026 with Ventura Securities Limited. The meeting will be a virtual one-to-one meeting and will not involve the sharing of confidential or unpublished price-sensitive information.
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd has announced a schedule of Analyst/Institutional Investor Meeting under SEBI regulations, to be held on July 30, 2026, with Tamohara Investment Managers Pvt. Ltd. The meeting will be a virtual one-to-one meeting and will not involve the sharing of confidential or unpublished price-sensitive information.
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd has announced a schedule of an investor meeting with Alchemy Capital Management on July 28, 2026, to discuss publicly available information.
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd reported Q1 FY27 financial results, with operating revenue of INR1,671 million, a 43% year-on-year growth and 25% sequential increase. EBITDA stood at INR323 million, representing an 86% growth Y-on-Y and 15% improvement over the previous quarter.
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd has announced a schedule of Analyst/Institutional Investor Meeting under SEBI regulations, to be held on 27 July 2026. The meeting will be a virtual group meeting hosted by ULJK Financial Services Pvt. Ltd. and will not involve the sharing of confidential or unpublished price-sensitive information.
Tatva Chintan Pharma Chem Ltd
Tatva Chintan Pharma Chem Ltd announced the closure of its trading window for all Designated Persons and their immediate relatives, effective from July 1, 2026. This closure is mandated by SEBI (Prohibition of Insider Trading) Regulations, 2015, and the Company's code, and will remain in effect until 48 hours after the declaration of the unaudited financial results for the quarter ending June 30, 2026. This is a standard compliance measure to prevent insider trading prior to financial disclosures.